只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 2026-07-13 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 21,275 | US$27.67 | US$588,679.25 | 164,853 | SEC |
| 2026-07-07 2026-07-09 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 600 | US$27.57 | US$16,542.00 | 186,128 | SEC |
| 2026-07-06 2026-07-07 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 53,722 | US$27.24 | US$146.34万 | 68,188 | SEC |
| 2026-07-02 2026-07-07 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 59,037 | US$27.33 | US$161.35万 | 76,651 | SEC |
| 2026-07-02 2026-07-07 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 24,734 | US$27.50 | US$680,185.00 | 186,728 | SEC |
| 2026-07-01 2026-07-02 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 45,634 | US$26.52 | US$121.02万 | 113,692 | SEC |
| 2026-07-01 2026-07-02 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 37,041 | US$26.93 | US$997,514.13 | 76,651 | SEC |
| 2026-06-30 2026-07-02 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 52,823 | US$25.72 | US$135.86万 | 76,651 | SEC |
| 2026-06-29 2026-06-30 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 63,212 | US$25.33 | US$160.12万 | 76,651 | SEC |
| 2026-06-26 2026-06-30 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 17,196 | US$25.18 | US$432,995.28 | 211,462 | SEC |
| 2026-06-26 2026-06-30 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 88,110 | US$25.33 | US$223.18万 | 76,651 | SEC |
| 2026-05-12 2026-05-13 | PRVA Privia Health Group, Inc. | Mehrotra Parth Director,Officer · Chief Executive Officer | 卖出（S） | 15,647 | US$22.64 | US$354,248.08 | 434,357 | SEC |
| 2026-05-11 2026-05-13 | PRVA Privia Health Group, Inc. | Mehrotra Parth Director,Officer · Chief Executive Officer | 卖出（S） | 105,439 | US$22.55 | US$237.76万 | 450,004 | SEC |
| 2026-05-11 2026-05-13 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 3,385 | US$22.60 | US$76,501.00 | 211,462 | SEC |
| 2026-05-04 2026-05-05 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 1,017 | US$24.96 | US$25,384.32 | 68,188 | SEC |
| 2026-05-04 2026-05-05 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 1,206 | US$25.00 | US$30,150.00 | 214,847 | SEC |
| 2026-05-01 2026-05-05 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn Director | 卖出（S） | 17,096 | US$24.99 | US$427,229.04 | 68,188 | SEC |
| 2026-05-01 2026-05-05 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 7,179 | US$25.03 | US$179,690.37 | 214,847 | SEC |
| 2026-04-02 2026-04-06 | PRVA Privia Health Group, Inc. | Mountcastle David Officer · EVP & Chief Financial Officer | 卖出（S） | 5,566 | US$20.85 | US$116,051.10 | 214,847 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PRVA | 168,489.8546 | 0 | 429,303.8405 | 39.25% | B, Q, N |